Familial Cancer

, Volume 4, Issue 3, pp 249–254 | Cite as

Gynecologic Cancers in Lynch Syndrome/HNPCC

Article

Abstract

Recent studies have estimated that the lifetime risk of endometrial cancer in women with Lynch syndrome/hereditary non-polyposis colorectal cancer syndrome (Lynch/HNPCC) is 40–60%. This risk equals or exceeds their risk for colon cancer. While much research has been done to define the natural history and molecular features of Lynch/HNPCC associated colon cancer, there has been considerably less research defining Lynch/HNPCC associated endometrial cancer. This article will review current information regarding the clinico-pathologic features of Lynch/HNPCC associated endometrial cancer. In addition, current consensus guidelines for endometrial cancer screening and prevention for women with Lynch/HNPCC will be discussed. Given the increased risk of multiple cancers, changing the name of this syndrome from hereditary non-polyposis colorectal cancer syndrome to Lynch Syndrome may benefit both patients and clinicians. Clinicians caring for women with Lynch/HNPCC may stress colon cancer screening and prevention without reviewing endometrial cancer risks and symptoms or screening and prevention options. Perhaps more importantly, women with Lynch/HNPCC may focus on colon cancer risks and lack understanding of endometrial cancer risks. With increasing evidence that women with Lynch/HNPCC have significant risks for both colon and endometrial cancers, we believe a multi-disciplinary approach to the management of these individuals is crucial.

Key words

endometrial cancer HNPCC-Lynch syndrome ovarian cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aarnio, M,  et al. 1999Cancer risk in mutation carriers of DNA-mismatch-repair genesInt J Cancer812148CrossRefPubMedGoogle Scholar
  2. 2.
    Dunlop, MG,  et al. 1997Cancer risk associated with germline DNA mismatch repair gene mutationsHum Mol Genet610510CrossRefPubMedGoogle Scholar
  3. 3.
    Lu, KH, Broaddus, RR 2001Gynecological tumors in hereditary nonpolyposis colorectal cancer: We know they are common – now whatGynecol Oncol822212CrossRefPubMedGoogle Scholar
  4. 4.
    Vasen, HF,  et al. 2001MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer familiesJ Clin Oncol19407480PubMedGoogle Scholar
  5. 5.
    Green, J,  et al. 2002Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutationDis Colon Rectum45122332CrossRefPubMedGoogle Scholar
  6. 6.
    Watson, P,  et al. 1994The risk of endometrial cancer in hereditary nonpolyposis colorectal cancerAm J Med9651620CrossRefPubMedGoogle Scholar
  7. 7.
    Wijnen, J,  et al. 1999Familial endometrial cancer in female carriers of MSH6 germline mutationsNat Genet231424CrossRefPubMedGoogle Scholar
  8. 8.
    Hendriks, YM,  et al. 2004Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillanceGastroenterology1271725CrossRefPubMedGoogle Scholar
  9. 9.
    Vasen, HF,  et al. 1994The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancerAnticancer Res1416758PubMedGoogle Scholar
  10. 10.
    Boks, DE,  et al. 2002Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancerInt J Cancer102198200CrossRefPubMedGoogle Scholar
  11. 11.
    Watson, P,  et al. 1998Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family membersCancer8325966CrossRefPubMedGoogle Scholar
  12. 12.
    Bos, M,  et al. 2004More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colonAm J Surg Pathol2870611PubMedGoogle Scholar
  13. 13.
    Berends, MJ,  et al. 2001MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancerInt J Cancer92398403CrossRefPubMedGoogle Scholar
  14. 14.
    Kuismanen, SA,  et al. 2002Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instabilityAm J Pathol16019538PubMedGoogle Scholar
  15. 15.
    Broaddus, RR,  et al. 2004Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndromeMod Pathol179819CrossRefPubMedGoogle Scholar
  16. 16.
    Zhou, XP,  et al. 2002Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumorsHum Mol Genet1144550CrossRefPubMedGoogle Scholar
  17. 17.
    Watson, P,  et al. 2001The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancerGynecol Oncol822238CrossRefPubMedGoogle Scholar
  18. 18.
    Burke, W,  et al. 1997Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies ConsortiumJAMA2779159CrossRefPubMedGoogle Scholar
  19. 19.
    Dove-Edwin, I,  et al. 2002The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinomaCancer94170812Google Scholar
  20. 20.
    Rijcken, FE,  et al. 2003Gynecologic screening in hereditary nonpolyposis colorectal cancerGynecol Oncol917480CrossRefPubMedGoogle Scholar
  21. 21.
    Dijkhuizen, FP,  et al. 2000The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: A meta-analysisCancer89176572CrossRefPubMedGoogle Scholar
  22. 22.
    Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 1987; 257(6): 796–800Google Scholar
  23. 23.
    Rebbeck, TR,  et al. 2002Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsN Engl J Med346161622CrossRefPubMedGoogle Scholar
  24. 24.
    Kauff, ND,  et al. 2002Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutationN Engl J Med346160915CrossRefPubMedGoogle Scholar
  25. 25.
    Chung, L,  et al. 2003Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancerObstet Gynecol10211525CrossRefPubMedGoogle Scholar
  26. 26.
    Lu, K,  et al. 2004Gynecological malignancy as a “Sentinel Cancer” for women with HNPCCGynecol Oncol92421Google Scholar
  27. 27.
    Umar, A,  et al. 2004Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityJ Natl Cancer Inst962618PubMedGoogle Scholar
  28. 28.
    Millar, AL,  et al. 1999Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometriumHum Mol Genet88239CrossRefPubMedGoogle Scholar
  29. 29.
    Soliman, PT,  et al. 2004Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 casesGynecol Oncol9445662CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Department of Gynecologic OncologyUT MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of PathologyUT MD Anderson Cancer CenterHoustonUSA

Personalised recommendations